Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 2326 AL 2340

Exploring promising minor natural phenolic compounds in neuroprotection-related preclinical models

Moreira Vasconcelos CF, Neugebauer AZ, Basto Souza R.

Basic Clin Pharmacol Toxicol. 2024 Jun;134(6):770-777. doi: 10.1111/bcpt.14006. Epub 2024 Apr 2.

Brain Penetrant NLRP3 Inhibitors: The Discovery of a Panacea?

Harrison D.

J Med Chem. 2024 Dec 12;67(23):20776-20779. doi: 10.1021/acs.jmedchem.4c02846. Epub 2024 Dec 2.

The Spectrum of Neurological Manifestations in Scrub Typhus

Rehani V, Sreen A, Anadure RK, Gupta S.

Neurol India. 2024 May 1;72(3):610-614. doi: 10.4103/neuroindia.NI_470_20. Epub 2024 Jun 30.

Ethnic background and distribution of clinical phenotypes in patients with probable progressive supranuclear palsy

Couto B, Di Luca DG, Antwi J, Bhakta P, Fox S, Tartaglia MC, Kovacs GG, Lang AE.

Parkinsonism Relat Disord. 2024 Jun;123:106955. doi: 10.1016/j.parkreldis.2024.106955. Epub 2024 Apr 15.

Duropathy as a rare motor neuron disease mimic: from bibrachial amyotrophy to infratentorial superficial siderosis

Iakovleva V, Verde F, Cinnante C, Sillani A, Conte G, Corsini E, Ciusani E, Erbetta A, Silani V, Ticozzi N.

BMC Neurol. 2024 Sep 2;24(1):309. doi: 10.1186/s12883-024-03799-6.

Fundamentals of deep brain stimulation for Parkinson's disease in clinical practice: part 2

Moscovich M, Aquino CH, Marinho MM, Barcelos LB, Felício AC, Halverson M, Hamani C, Ferraz HB, Munhoz RP.

Arq Neuropsiquiatr. 2024 Apr;82(4):1-9. doi: 10.1055/s-0044-1786037. Epub 2024 Apr 23.

Future Directions of MR-guided Focused Ultrasound

Grogan DP, Abduhalikov T, Kassell NF, Moosa S.

Magn Reson Imaging Clin N Am. 2024 Nov;32(4):705-715. doi: 10.1016/j.mric.2024.02.004. Epub 2024 Apr 1.

Case Report: A Case of a Patient with Smith-Magenis Syndrome and Early-Onset Parkinson's Disease

Stern T, Hussein Y, Cordeiro D, Sadis H, Garin-Shkolnik T, Spiegel R, Cohen S, Harari R, Schlesinger I, Stern S.

Int J Mol Sci. 2024 Aug 2;25(15):8447. doi: 10.3390/ijms25158447.

[Mechanisms Underlying the Propagation of α-Synuclein Seeds Derived from the Blood of Patients with α-Synucleinopathies]

Okuzumi A, Hatano T, Hattori N.

Brain Nerve. 2024 Jun;76(6):767-772. doi: 10.11477/mf.1416202676.

Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases

Tapia-Arellano A, Cabrera P, Cortés-Adasme E, Riveros A, Hassan N, Kogan MJ.

J Nanobiotechnology. 2024 May 13;22(1):248. doi: 10.1186/s12951-024-02526-0.

Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease

Casciano F, Zauli E, Celeghini C, Caruso L, Gonelli A, Zauli G, Pignatelli A.

Int J Mol Sci. 2024 Jan 30;25(3):1689. doi: 10.3390/ijms25031689.

Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases

Sarkar S, Roy D, Chatterjee B, Ghosh R.

Metabolomics. 2024 Mar 8;20(2):37. doi: 10.1007/s11306-024-02100-7.

Potential effects of the most prescribed drugs on the microbiota-gut-brain-axis: A review

Garg K, Mohajeri MH.

Brain Res Bull. 2024 Feb;207:110883. doi: 10.1016/j.brainresbull.2024.110883. Epub 2024 Jan 18.

Associations of environmental factors with neurodegeneration: An exposome-wide Mendelian randomization investigation

Li D, Zhou L, Cao Z, Wang J, Yang H, Lyu M, Zhang Y, Yang R, Wang J, Bian Y, Xu W, Wang Y.

Ageing Res Rev. 2024 Mar;95:102254. doi: 10.1016/j.arr.2024.102254. Epub 2024 Feb 29.

Pathogenesis of Parkinson's disease: from hints from monogenic familial PD to biomarkers

Hattori N, Funayama M, Imai Y, Hatano T.

J Neural Transm (Vienna). 2024 Jun;131(6):709-719. doi: 10.1007/s00702-024-02747-5. Epub 2024 Mar 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias